GLENMARK PHARMACEUTICALS LTD.
BSE: 532296
Shareholding Trends
Ownership split
PromoterPublicOthers
Institutional detail
FII / FPIDII
Q1 FY27
Corporate Events
Board MeetingGLENMARK
20265Nov
Board Meeting
The Board of Directors meeting is scheduled to consider and …
BSE Filing ↗ Board MeetingGLENMARK
202611Sep
Board Meeting
To receive, consider, approve and adopt the Audited Standalo…
BSE Filing ↗ Board MeetingGLENMARK
202631Jul
Board Meeting
The Board of Directors will meet to consider and approve the…
BSE Filing ↗ Board MeetingGLENMARK
202629May
Board Meeting
The Board of Directors will meet to consider and approve the…
BSE Filing ↗ Board MeetingGLENMARK
202414Nov
Board Meeting
Consider and approve the Unaudited Financial Results
BSE Filing ↗ Board MeetingGLENMARK
202424May
Board Meeting
Consider and approve the Standalone and Consolidated Audited…
BSE Filing ↗ Board MeetingGLENMARK
202310Nov
Board Meeting
Consider and approve Unaudited Financial Results for the sec…
BSE Filing ↗ Board MeetingGLENMARK
20235Oct
Board Meeting
Consider and approve the Sale of Equity Shares of Glenmark L…
BSE Filing ↗ Board MeetingGLENMARK
202311Aug
Board Meeting
Consider and approve Unaudited Financial Results for the Fir…
BSE Filing ↗